coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    The Picton PCN, Liverpool (LAD) · Health Inequalities Profile

    PCN U53230 · NHS Cheshire and Merseyside Integrated Care Board · 6 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    45,138

    Registered population

    65.2% aged 18–64

    12.9%

    Aged 65+

    ICB 19.0% · England 17.9%

    26.3%

    Ethnic minority (non-White)

    7.3% Asian · England 9.6%

    77.3%

    In IMD quintile 1

    ICB 31.9% · England 21.0%

    ~27,404

    Core20 residents (est.)

    Resident basis; registered basis ~35,224 · see page 3

    6,021

    Hypertension register

    -1.18% in 3 yrs · England +5.60%

    812

    SMI register

    9.7% of Liverpool (LAD)'s

    1,314

    COPD register

    Reviews -1.79% in 3 yrs

    Forecast to 2030

    6,278

    Hypertension patients, 2030

    +257 on today

    73.2%

    QRISK ≥20% on statins, 2030

    +2.69pp over 3 yrs

    2.9%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    52.7%
    Cervical screening aged 25-49 trails all benchmarks.

    Coverage at 52.7% is 14.1 pp below England (66.8%) and fell 3.9% over 2023 to 2025, which may reflect recall gaps to audit.

    63.7%
    Age-five second MMR dose lags national target.

    In Q1 2025/26, coverage is 63.7% (England 82.8%), 31.3 pp below the 95.0% target and 20 pp below first-dose coverage at 83.7%.

    77.2%
    Asthma review coverage exceeds national and local rates.

    Annual reviews reach 77.2% (England 65.7%; Liverpool 64.3%; ICB 62.3%), though about 610 of 2,691 register patients remain unreviewed for targeted recall.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    A younger population with 12.9% aged 65+ and 26.3% ethnic minority residents

    Across 45,138 registered patients, the PCN has a younger profile: 12.9% are aged 65+, below Liverpool (LAD) (15.6%), NHS Cheshire and Merseyside ICB (19.0%) and England (17.9%), while 21.9% are aged 0-17 (Liverpool LAD 19.8%; ICB 19.2%; England 19.6%). Census data shows a 73.7% White resident share, lower than Liverpool (LAD) (84.0%), the ICB (93.0%) and England (81.1%), giving a 26.3% non-White share. ONS projections indicate 3.9% list growth to 2030 (Liverpool LAD 3.0%; ICB 2.3%; England 2.3%). This profile may direct demand toward paediatric access and adapted prevention; projection methods remain unverified.

    Age profile

    0–1721.9%
    18–6465.2%
    65+12.9%

    65+: ICB 19.0%, England 17.9%

    Ethnicity

    White73.7%
    Asian7.3%
    Black7.3%
    Other6.1%
    Mixed5.5%

    Older people · falls rows are Liverpool (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Liverpool LA)3,0352,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)82.8%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)50.7%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Liverpool LA)1,6521,0219552024/25
    Falls deaths, all ages, per 100,000 (Liverpool LA)27.518.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    With 77.3% Core20 patients, deprivation is high and spans 36.0 pp between practices

    The PCN average IMD decile is 2.2, compared to 3.4 in Liverpool (LAD), 5.2 in NHS Cheshire and Merseyside ICB and 5.5 in England. Registered patients in the Core20 cohort reach 77.3% (Liverpool LAD 54.9%; ICB 31.9%; England 21.0%). Practice shares span 36.0 pp, from 53.94% at Sefton Park Medical Centre to 89.92% at Picton Green. Beacon Health Kensington holds the largest Core20 volume at an estimated 8,400 patients. Practice estimates total 35,224, differing from the resident decile 1+2 estimate of 27,404.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Picton Green89.9% · 3,043 patients
    Dunstan Village87.8% · 7,433 patients
    Earle Road87.4% · 3,334 patients
    Beacon Health87.1% · 8,400 patients
    Green Lane77.0% · 7,750 patients
    Sefton Park53.9% · 5,264 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    812

    SMI register

    1.75% recorded prevalence

    297

    Learning disability register

    0.64% recorded prevalence

    14

    Care homes, 578 beds

    In the PCN catchment

    10.3%

    Provide unpaid care

    Liverpool (LAD), Census 2021

    Severe mental illness prevalence is 1.8% (812 patients), above Liverpool (LAD) (1.4%), NHS Cheshire and Merseyside ICB (1.1%) and England (1.0%), while learning disability prevalence is 0.6% (297 patients; LAD 0.6%; ICB 0.6%; England 0.6%). Catchment data records 14 care homes and 578 beds, though resident occupancy is unconfirmed. With SMI register prevalence above Liverpool, ICB and England rates, annual physical-health checks for this group could be an essential workload.

    Severe mental illness: physical health checks

    Severe mental illness prevalence is 1.8% (England 1.0%). Recorded blood pressure checks reach 80.1% (England 83.4%) and BMI checks 79.6% (England 82.1%). SMI physical health checks trail national rates, which local audit could test.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    6,021

    Hypertension register

    −1.18%

    Register growth, 3 yrs

    Liverpool (LAD) +2.01% · England +5.60%

    +0.40pp

    BP control, under 80

    ≤140/90 · −0.60pp aged 80+

    +257

    More patients by 2030

    Forecast 6,278 (12.68%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 13.0% (6,021 patients), below Liverpool (LAD) (14.0%), NHS Cheshire and Merseyside ICB (16.8%), and England (15.2%), with three-year prevalence change at -1.2% (England +5.6%). Blood pressure control for patients under 80 is 61.4%, trailing Liverpool (LAD) (67.0%), the ICB (66.4%), and England (67.8%). Across practices, recorded prevalence spans from 9.4% at Picton Green to 17.3% at Green Lane Medical Centre. Lower blood pressure control than national benchmarks may indicate review or treatment escalation gaps, which clinical audit across member practices could test.

    Lipids and statins

    For patients with QRISK >= 20%, lipid-lowering therapy reaches 67.5%, above Liverpool (LAD) (65.6%), NHS Cheshire and Merseyside ICB (63.2%), and England (63.6%). Higher therapy coverage than England is consistent with strong primary prevention that the PCN could sustain through routine annual medication recalls.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202675,891£1.50£1.71£1.86£113,836
    Cardiovascular (all), 2025105,172£3.70£4.37£3.33£389,136

    In 2026, the PCN prescribed 75,891 lipid-regulating items at £1.50 per item, below Liverpool (LAD) (£1.82), NHS Cheshire and Merseyside ICB (£1.71), and England (£1.86), spending £27,321 less than at England's unit cost. Lower unit cost than national benchmarks provides a baseline for review, though unit cost does not measure efficiency or formulary choices.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +3.14%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −1.39%

    Asthma prevalence, PCN 3-yr % change

    COPD prevalence is 2.8% (1,314 patients), above England (1.9%) and NHS Cheshire and Merseyside ICB (2.5%) but below Liverpool (LAD) (3.0%), with three-year change of -5.0% (England +2.6%). Asthma prevalence is 6.2% (2,691 patients; England 6.6%). Annual reviews exceed England for COPD (83.6% vs 76.4%) and asthma (77.2% vs 65.7%), though an estimated 614 asthma patients lacked a recorded review. Prescribing of 2,215 asthma items per 1,000 aged 5-19 (England 1,488 rate) may reflect elevated need, which local audit could test.

    Cancer register and children's immunisation

    Cancer prevalence is 2.7% (1,264 patients), below England (3.8%). At 24 months, MMR dose 1 coverage is 70.5%, below England (88.3%) and the 95.0% target. At age 5, MMR dose 2 is 63.7% (England 82.8%), trailing dose 1 (83.7%) by 20 pp across the PCN and by 40 pp at Beacon Health Kensington. This cross-sectional difference may reflect recall gaps that practice audit could test.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months84.6%

    England 91.0%

    6-in-1 complete primary course at 24 months75.9%

    England 92.2%

    MMR dose 1 at 24 months70.5%

    England 88.3%

    MMR dose 2 at age 563.7%

    England 82.8%

    4-in-1 pre-school booster at age 560.7%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.5%

    Cheshire and Merseyside ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,640

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Cheshire and Merseyside ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%11%2,354
    Breast87.1%85.4%11%2,083
    Prostate52.3%53.2%12%2,037
    Bowel44.9%47.0%16%1,674
    Skin cancer86.9%87.8%21%932

    In 2022, 55.5% of staged cancers (7,482 of 13,490) across NHS Cheshire and Merseyside ICB were diagnosed at stage 1 or 2, compared with 55.3% in England and 19.5 pp below the 75.0% national ambition by 2028. Known-stage coverage was 72.8% (13,490 of 18,522). Reaching 75.0% requires about 2,640 extra early-stage diagnoses annually across the ICB. These system figures do not reflect PCN performance. Within the PCN, cervical screening coverage in women aged 25-49 is 52.7%, trailing England (66.8%) and Liverpool (60.4%), falling 3.9% over three years (England -1.0%), with Beacon Health Kensington at 39.2%. Lagging screening uptake risks delayed detection, warranting targeted practice recall.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In provisional data for Jul 2026, Liverpool Women's NHS Foundation Trust achieved 69.1% on the 62-day referral to treatment standard (19 of 27.5 pathways), trailing the 85.0% standard, Liverpool University Hospitals NHS Foundation Trust (73.3%), England (71.2%) and NHS Cheshire and Merseyside Integrated Care Board (76.2%). The 28-day faster diagnosis standard reached 75.7% (operational standard 75.0%; England 79.3%). For non-obstetric ultrasound, 6.1% of patients waited 6+ weeks, compared with 4.4% at Liverpool University Hospitals NHS Foundation Trust and 19.6% across England. These provider figures describe secondary care rather than PCN performance. Provider treatment delays could affect patient outcomes across referred.

    Pathways within standard (%)Liverpool Women'sLiverpoolMersey and West LancashireCheshire and Merseyside ICBEngland
    28-day faster diagnosis (75%)75.7375.4772.3977.2579.32
    31-day treatment (96%)85.4290.5195.4695.7192.50
    62-day referral to treatment (85%)69.0973.2677.9676.2371.16
    Community services activityLiverpool residentsCheshire and Merseyside ICB
    Care contacts127,380541,280
    Referrals15,67597,150
    Patients with a contact24,970146,240

    Community services (residents of Liverpool), Jun 2026 (provisional). In provisional Jun 2026 community data, Liverpool residents aged 65 and over accounted for 65.4% of borough contacts (83,300 of 127,380). This captures borough-level activity rather than PCN caseload. Substantial older-age borough community demand underscores the need for close system coordination.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice QOF and vaccination achievement vary widely alongside marked deprivation and low survey response

    In 2025/26, overall QOF achievement reached 79.7% at Beacon Health Kensington, and 89.5% at Dunstan Village Group Practice and Sefton Park Medical Centre (England 92.5%). Vaccination and immunisation achievement spanned 12.2 pp, from 15.6% at Beacon Health Kensington to 27.8% at Earle Road Medical Centre (England 55.2%). Points do not establish population reach.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Green Lane12577.058.8%73.4%86.9%
    Sefton Park9353.970.9%70.6%86.2%
    Dunstan Village7887.847.8%82.7%82.8%
    Earle Road7387.434.2%57.2%74.8%
    Picton Green9589.948.9%71.5%73.6%
    Beacon Health8887.150.9%70.2%68.5%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNLiverpool (LAD)AssetPCNLiverpool (LAD)
    Care homes (catchment)14 (578 beds)n/aSchools (catchment)114n/a
    Children's centres426Places of worship74240
    Libraries417Homelessness support (VCS)n/a1
    Primary schools (LA maintained)2091Primary academies420
    Special schools28

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Asthma annual review catch-up

    Annual asthma review coverage is 77.2% (above England 65.7%, Liverpool 64.3% and ICB 62.3%), yet applying this rate to the 2,691 register leaves 614 (about 610) patients unreviewed. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Childhood MMR and pre-school recall

    At 24 months (112 children), MMR1 is 70.5% (24.5 pp below 95.0%; England 88.3%). At age 5 (135 children), MMR2 is 63.7% (20 pp below MMR1 at 83.7%, and 40 pp below at Beacon Health Kensington). Moderate effort to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Option 3

    Cervical screening and early diagnosis

    PCN cervical screening (aged 25-49) is 52.7% (England 66.8%; Liverpool 60.4%), falling 3.9% (England -1.0%), and 39.2% at Beacon Health Kensington. ICB early-stage cancer is 55.5% (19.5 pp below 75.0%). Low cost, quick to run.

    Evidence base: the cancer register is the cohort for breast, bowel and cervical screening and for urgent suspected-cancer referral; where patients present as emergencies, the screening and referral steps have failed and symptom awareness needs support.

    Policy anchor: Core20PLUS5 — 75% of cancers diagnosed at stage 1 or 2 by 2028.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Culturally tailored access review (p2)WhiteNeighbourhood health framework · Core20PLUS5 approachPCN
    Two-track Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical health checks (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension blood pressure control review (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    MMR second dose recall audit (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall outreach (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Option 1 · Asthma annual review catch-up (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Asthma management items prescribed per 1000 5-19 PopulationCore20PLUS5 respiratoryPCN
    Option 2 · Childhood MMR and pre-school recall (p12)MMR dose 1 coverage at 24 months · 6-in-1 complete primary course at 24 months · MMR dose 1 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Option 3 · Cervical screening and early diagnosis (p12)Cancer register · Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs) · Cancers diagnosed at stage 1 or 2 (All cancer sites)Core20PLUS5, 75% stage 1–2 by 2028PCN & Practice & ICB
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15